Mind Medicine (MindMed) Inc.
General ticker "MNMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $682.7M (TTM average)
Mind Medicine (MindMed) Inc. follows the US Stock Market performance with the rate: 63.8%.
Estimated limits based on current volatility of 2.8%: low 12.03$, high 12.73$
Factors to consider:
- Total employees count: 74 (+29.8%) as of 2024
- Top business risk factors: Transition to commercialization, Drug development risks, Regulatory and compliance, Cybersecurity threats, Reimbursement risks
- Current price 12.8% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.78$, 11.02$]
- 2025-12-31 to 2026-12-31 estimated range: [2.23$, 6.95$]
Financial Metrics affecting the MNMD estimates:
- Negative: with PPE of -4.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.81 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: 0.01 < Interest expense per share per price, % of 0.46
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 79.91 > 63.39
- Positive: Investing cash flow per share per price, % of -0.01 > -0.66
Short-term MNMD quotes
Long-term MNMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $66.33MM | $93.87MM | $103.92MM |
| Operating Income | $-66.33MM | $-93.87MM | $-103.92MM |
| Non-Operating Income | $9.54MM | $-1.87MM | $-4.76MM |
| Interest Expense | $0.00MM | $0.92MM | $2.28MM |
| R&D Expense | $36.17MM | $52.12MM | $65.30MM |
| Income(Loss) | $-56.80MM | $-95.73MM | $-108.68MM |
| Profit(Loss)* | $-56.80MM | $-95.73MM | $-108.68MM |
| Stockholders Equity | $150.92MM | $78.13MM | $241.45MM |
| Assets | $169.99MM | $124.54MM | $302.15MM |
| Operating Cash Flow | $-50.14MM | $-64.36MM | $-79.13MM |
| Investing Cash Flow | $-0.31MM | $0.08MM | $-0.03MM |
| Financing Cash Flow | $59.05MM | $21.85MM | $253.20MM |
| Earnings Per Share** | $-1.84 | $-2.44 | $-1.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.